In summary, these findings confirm that NDR1 phosphorylates FBXO11 at Ser187, and this phosphorylation-mediated FBXO11 ubiquitination of β-catenin regulates the EMT and prostate cancer progression. This evidence concerns the gene FBXO11 and prostate cancer.